Ascensia Diabetes Care

FDA Regulatory Profile

Ascensia Diabetes Care appears in FDA public data with 0 recalls, 6 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on August 27, 2026.

Summary

Total Recalls
0
510(k) Clearances
6
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K260545CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring SysteAugust 27, 2026
K231679CONTOUR® PLUS BLUE Blood Glucose Monitoring SystemFebruary 23, 2024
K193407Contour® next GEN Blood Glucose Monitoring SystemDecember 23, 2021
K210687CONTOUR® NEXT ONE Blood Glucose Monitoring SystemAugust 11, 2021
K191286CONTOUR® NEXT Blood Glucose Monitoring System, CONTOUR® NEXT USB Blood Glucose Monitoring System, CONovember 8, 2019
K160682CONTOUR NEXT ONE Blood Glucose Monitoring SystemNovember 17, 2016